Jin Song

Title: The Innovative Contributions of Jin Song

Introduction

Jin Song is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection of pancreatic cancer. With a total of 3 patents to his name, his work has the potential to impact patient outcomes significantly.

Latest Patents

Jin Song's latest patents focus on compositions and methods for detecting pancreatic cancer. These methods involve measuring the level of CA19-9 polysaccharide in a sample from a subject, relative to a reference. Additionally, they assess the levels of specific polynucleotides or polypeptides, including markers such as OPN, MIA, CEACAM-1, MIC-1, SPON1, HSP27, POSTN, and LGALS3BP. An increased level of CA19-9 polysaccharide and the aforementioned markers relative to a reference indicates the presence of pancreatic cancer in the subject.

Career Highlights

Throughout his career, Jin Song has worked with prestigious organizations, including The Johns Hopkins University and Vermillion, Inc. His experience in these institutions has allowed him to develop and refine his innovative methods for cancer detection.

Collaborations

Jin Song has collaborated with esteemed colleagues such as Zhen Zhang and Daniel Wan-Yui Chan. These partnerships have contributed to the advancement of his research and the development of his patents.

Conclusion

Jin Song's work in the field of pancreatic cancer detection exemplifies the importance of innovation in medical diagnostics. His contributions are paving the way for improved detection methods that could ultimately save lives.